RxDoctor Payments Data

Steven Cherrington, DO

Family Medicine · Lindon, UTNPI 1871608893

Payments from drug & device makers

$8,315in general payments, 2019–2025

Across 408 payments — averaging $20.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lucid Diagnostics Inc.$2K
  • AbbVie$1K
  • AstraZeneca$777
  • Lilly USA, LLC$353
  • Abbott$300
  • Novo Nordisk$261
  • plus $3K from 47 others

What the payments were for

  • Food & beverage$6,365100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,315 in reported general payments places this provider in the 90th percentile of 928 family medicine providers in Utah.

See all family medicine providers in Utah

Medicare billing

Part B allowed, 2024
$42,484
Medicare patients
132
Services billed
2,400

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide70$84,460
JardianceEmpagliflozin61$58,494
OzempicSemaglutide48$47,539
Soliqua 100-33Insulin Glargine/Lixisenatide20$23,660
EliquisApixaban24$21,693
FarxigaDapagliflozin Propanediol25$18,208
MyrbetriqMirabegron34$17,707
Repatha SureclickEvolocumab12$6,568
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl73$3,846
Levothyroxine Sodium194$2,260
Omeprazole122$1,708
Liothyronine Sodium29$1,678
Gabapentin104$1,630
Celecoxib69$1,620
Lantus SolostarInsulin Glargine,hum.Rec.Anlog15$1,365

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$353$84,46070 claims
Boehringer IngelheimJardiance$73$58,49461 claims
Novo NordiskOzempic$261$47,53948 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$169$23,66020 claims
PfizerEliquis$205$21,69324 claims
AstraZenecaFarxiga$777$18,20825 claims
Astellas Pharma US IncMyrbetriq$223$17,70734 claims
AbbVieSynthroid$1,356$48616 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 928 family medicine providers in Utah.

Other family medicine in Lindon

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →